Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
2020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol [...]
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody stripping reagent combined [...]
Visikol, a leading drug discovery company focused on advanced imaging, digital pathology and 3D cell culture assays, announced today [...]
3D cell culture models (e.g. organoids, spheroids, micro-tissues) provide researchers with the ability to better mimic the in vivo [...]
Visikol is a leading provider of advanced cell culture assays and has recently been expanding its portfolio of in [...]
Today, it is undeniable that we as a society are going through an absolutely unprecedented time in human history [...]
To kick off the new year, Visikol has announced that it has expanded its footprint in New Jersey by [...]
We want to wish all of our friends, family, clients, customers and collaborators Happy Holidays! 2019 has been a [...]